The Prevalence and Cost of Type 2 Diabetes with Chronic Kidney Disease in Ontario

Client: IQVIA Solutions Canada Inc.

Project ID: P2018-043 / 2019 0970 154 000

Research Question/Objectives: Kidney disease, known as nephropathy, is a complication associated with long-term diabetes. Approximately half of all patients diagnosed with type 2 diabetes will develop chronic kidney disease, which increases their risk of kidney failure and cardiovascular disease. Chronic kidney disease in diabetic patients is a major but under-recognized contributor to the burden of diabetes, both to the patient and healthcare system. The objective of the current research project is to study Ontario patients with DM and CKD, to quantify the economic burden to the public payer. In addition, the current project team would like to know the prevalence of these patients.

Research objectives:

• Estimate the prevalence of patients with DM and CKD in Ontario.
• Describe the demographic and baseline characteristics of patients with DM and CKD and who are incident for DM-related outcomes (death, kidney transplant, dialysis, double serum creatinine).
• Calculate the per-patient healthcare costs from the Ontario public payer’s perspective for patients with DM and CKD who are incident to DM-related outcomes death, kidney transplant, dialysis, double serum creatinine.

Results:

• January 2021